Posted , 3 users are following.
There has been an increase in the number of reports of severe eye irritation in patients using reformulated Xalatan eye drops. The MHRA has issued advice to report promptly (within a week) if patients experience eye irritation (e.g. excessive watering) severe enough to make them consider stopping treatment. Prescribers should consider a different formulation if necessary.
1 like, 8 replies